Back to dashboard
MedicaidReimbursementMedium impact

Newsletter Vol. 4, No. 17

New Jersey Medicaid·NJ · Endocrinology, Family Medicine, Internal Medicine·Provider Notice
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply
—

Summary

New Jersey Medicaid has reduced maximum fee allowances for blood glucose monitoring devices effective November 2024. Home blood glucose monitors (E0607) are now reimbursed at $25.00, while monitors with special features (E0607-BR) have no reimbursement.

Action Required

Action needed
Immediately: Billing team must update fee schedules for New Jersey Medicaid claims to reflect new maximum allowances - E0607 at $25.00 maximum, E0607-BR with no reimbursement. Review existing claims with dates of service November 1 or later for potential adjustments. Contact New Jersey Medicaid Chief Pharmaceutical Consultant at provided number for questions.

Affected Billing Codes

E0607

Related policy hubs